Evidence map›Paper›PMID 41432816›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

The burden of ischemic stroke and its attributable risk factors among people aged 15-49 years in Asia, 1990-2021: results from the global burden of disease study 2021.

Zengxin Han, Tongyan Liu, Shuo Wang, Wei Sun, Wenqi Qiao

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zengxin HanAcupuncture and moxibustion Department, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150000, China.
Tongyan LiuAcupuncture and moxibustion Department, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150000, China.
Shuo WangAcupuncture and moxibustion Department, The First Hospital Of Harbin, Harbin, Heilongjiang, 150000, China.
Wei SunAcupuncture and moxibustion Department, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150000, China.
Wenqi QiaoGeriatrics Department, The Third Affiliated Hospital of Heilongjiang University of Chinese Medicine, No. 2 Xiangjiang Road, Xiangfang District, Harbin City, Heilongjiang Province, 150000, China. qiaowenqi2023@163.com.ORCID http://orcid.org/0009-0009-8035-9008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study extensively investigated the disease burden of ischemic stroke (IS) in young and middle-aged populations (15-49 years old) in Asia from 1990 to 2021.

methodsWe used data from the 2021 Global Burden of Disease (GBD) to quantify health burden. Risk factors were analyzed. Joinpoint regression models described the temporal trend of the disease burden. The Bayesian age-period-cohort (BAPC) model was applied for forecasting the disease burden of IS till 2040.

resultsThe incidence of IS among young and middle-aged people in Asia increased by more than 80%, and IS mortality and disability adjusted life years (DALYs) increased by more than 40% over the past 32 years. The rising trend of incidence was the most significant (average annual percentage change [AAPC] = 1.8887, P < 0.001). In 2021, the incidence, mortality, and DALYs in East Asia were the highest. In 2021, the disease burden of males in the age group of 15-49 was greater than that of females, while the 45-49 age group had the most severe disease burden. Risk factor analysis shows that high systolic blood pressure was the biggest risk factor. By 2040, the IS incidence rate among young and middle-aged people aged 15-49 in Asia will reach 25.20, an increase of about 12% compared to 2022.

conclusionFor 15-49-year-old Asians, the disease burden of IS increases continuously. In the future, medical measures for this age group should focus on prevention. This trend will become even more serious if no intervention is applied in the future.

Indexed as

Cost of IllnessGlobal Burden of DiseaseIschemic StrokeAdolescentAdultAsiaDisability-Adjusted Life YearsFemaleHumansIncidenceMaleMiddle AgedRisk FactorsYoung AdultAsiaDisease burden studyIschemic strokePredictionRisk factorYoung and middle-aged population (15–49 years old)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.